Actos Lawsuit News: Appellate Court Reinstates $6.5 Million Jury Award

Actos Lawsuit News: Appellate Court Reinstates $6.5 Million Jury Award

In a significant development in the Actos litigation, the California State Appeals Court for the Second District last week reinstated a cancer patient and spouse’s $6.5 million jury award against the makers of Actos, a diabetes medication. The appellate court’s decision reaffirms the importance and role of the jury in deciding claims.

[Read more…]

Federal Jury Awards Punitive Damages In Actos Bladder Cancer Trial

Federal Jury Awards Punitive Damages in Actos Trial

A federal jury in Louisiana yesterday ordered Takeda Pharmaceutical Company and Eli Lilly & Company to pay $1,475,000 in compensatory damages, finding that they failed to adequately warn about bladder-cancer risks of their diabetes medicine Actos. Jurors also found that Takeda and Lilly executives acted with wanton and reckless disregard for patient safety in their handling of the drug, and awarded a total of $9 billion in punitive damages against both companies.

[Read more…]